Profile
Mitzi Martinez-Montgomery worked as a Vice President in various pharmaceutical companies including Oncolix, Opexa Therapeutics, and PharmaFrontiers Corp.
She also worked as a Director of Preclinical Development at Repros Therapeutics, Inc. She completed her undergraduate degree from Vanderbilt University in 1976 and earned her doctorate degree from Auburn University in 1992.
Former positions of Mitzi Martinez-Montgomery
| Companies | Position | End |
|---|---|---|
| PharmaFrontiers Corp. | Corporate Officer/Principal | 2006-06-18 |
| REPROS THERAPEUTICS INC | Corporate Officer/Principal | - |
Opexa Therapeutics, Inc.
 Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | Corporate Officer/Principal | - |
Oncolix, Inc. /Old/
 Oncolix, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Oncolix, Inc. engages in the development and manufacture of biopharmaceutical products for the treatment of breast cancer. It offers Prolanta, a targeted therapeutic protein for the treatment of ovarian and breast cancer. The company was founded in November 2006 and is headquartered in Houston, TX. | Chief Tech/Sci/R&D Officer | - |
Training of Mitzi Martinez-Montgomery
| Vanderbilt University | Undergraduate Degree |
| Auburn University | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Repros Therapeutics, Inc.
 Repros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Repros Therapeutics, Inc. is a development stage biopharmaceutical company, which focuses on the development of drugs to treat hormonal and reproductive systems disorders. Its products include Enclomiphene and Proellex. The company was founded on August 20, 1987 and is headquartered in The Woodlands, TX. | Health Technology |
| PharmaFrontiers Corp. | Health Technology |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | Health Technology |
Oncolix, Inc. /Old/
Oncolix, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Oncolix, Inc. engages in the development and manufacture of biopharmaceutical products for the treatment of breast cancer. It offers Prolanta, a targeted therapeutic protein for the treatment of ovarian and breast cancer. The company was founded in November 2006 and is headquartered in Houston, TX. | Health Technology |
- Stock Market
- Insiders
- Mitzi Martinez-Montgomery
